背景: 免疫疗法组合可能是克服对现有疗法的耐药性的有希望的策略。AFM24是一类第一个双特异性四价先天性细胞增殖剂,结合先天性效应细胞(NK细胞和...查看全文
Affimed(AFMD)06-07 05:15
$Affimed(AFMD)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-156194 Act: 34 Size: 77 KB 网页链接查看全文
Affimed(AFMD)05-28 18:55
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-147572 Act: 34 Size: 179 KB 网页链接查看全文
Affimed(AFMD)06-12 20:05
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-159605 Act: 34 Size: 429 KB 网页链接查看全文
Affimed(AFMD)06-27 04:55
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-169160 Act: 34 Size: 38 KB 网页链接查看全文
Affimed(AFMD)06-03 18:15
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-152290 Act: 34 Size: 41 KB 网页链接查看全文
Affimed(AFMD)05-24 05:25
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-146116 Act: 34 Size: 37 KB 网页链接查看全文
Takeabreak2020-12-15 11:13
$居里(CRIS)$ 2020很特别,都是曾经令人心碎的票,一不注意,咸鱼翻身,而且还上天了。。。$延龄草治疗(TRIL)$ $Affimed(AFMD)$查看全文
Takeabreak2020-12-10 11:39
$Otonomy(OTIC)$ 盘后新高。市值2.3 vs 11 of FREQ
4X 差距。至少一步到位缩小一半。$10
$Affimed(AFMD)$ $Rocket制药(RCKT)$查看全文
Spica2020-12-08 22:16
$Fate Therapeutics(FATE)$ 最近ASH会议,几家CAR-NK的公司都要上天了$Nkarta(NKTX)$ $Affimed(AFMD)$查看全文
蹊之美股生物医药2020-12-08 20:55
作者:林出
微信公众号:蹊之美股生物医药 / AlleyMazeResearch
标的公司:Affimed N.V. (NASDAQ:AFMD)
Affimed N.V.(AFMD)在第62届美国血液学学会年会和博览会上宣布了关于AFM13的临床数据集。哥伦比亚大学内科和外科学院以及纽约Presbyterian医院的医学助理教授Dr. Ahmed Sawas...查看全文
Replix锐璞美股2020-12-08 01:31
今天小锐是收获的一天,以前天天喝凉水,今天终于喝口汤了。$Affimed(AFMD)$ $Fate Therapeutics(FATE)$ $特斯拉(TSLA)$查看全文
Replix锐璞美股2020-12-06 14:42
$Affimed(AFMD)$ AFMD股价52周新高!我们的覆盖报告如下:网页链接。AFMD也是一家我们长期跟踪的公司,我们跟踪这家公司也有三年了,这家公司的双抗技术很有特点,公司估值相比于中国同行可谓白菜价,又有大公司背书。恭喜持有的朋友们!
$康方生物-B(09926...查看全文
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-169160 Act: 34 Size: 38 KB 网页链接
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-159605 Act: 34 Size: 429 KB 网页链接
$Affimed(AFMD)$ 6-K/A [Amend] Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-156194 Act: 34 Size: 77 KB 网页链接
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-152290 Act: 34 Size: 41 KB 网页链接
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-147572 Act: 34 Size: 179 KB 网页链接
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-146116 Act: 34 Size: 37 KB 网页链接
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-080581 Act: 34 Size: 168 KB 网页链接
$Affimed(AFMD)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001104659-24-040310 Act: 34 Size: 12 MB 网页链接
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-064790 Act: 34 Size: 11 KB 网页链接
$Affimed(AFMD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-24-059965 Act: 34 Size: 29 KB 网页链接